Celesio AG (CLS1) - Financial and Strategic SWOT Analysis Review

  • ID: 1322639
  • SWOT Analysis
  • 38 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • CVS Health Corporation
  • Europa Apotheek Venlo BV
  • Mediq NV
  • MORE
Celesio AG (CLS1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights:

Celesio AG (Celesio), is a subsidiary of McKesson Corporation, is an international trading company. It provides an array of services for pharmaceutical and healthcare markets in Europe. The company operates a large network of pharmacies, which provides drugs and health related services to patients. Its retail network includes both own and managed pharmacies. Celesio apart from prescription and non-prescription pharmaceuticals, it provides blood pressure, cholesterol and diabetes testing services. The company also undertakes pharmacy and laboratory equipment business; and property development for pharmacies. It works in alliance with pharmacies and hospitals through a network of branches across Europe. Celesio is headquartered in Stuttgart, Germany.

Celesio AG Key Recent Developments

Jun 23,2017: Celesio revenue grows by 5.8 percent on constant currency basis and excluding disposals
Feb 03,2017: Celesio UK appoints new digital director
Jan 16,2017: Celesio announces management changes
Nov 22,2016: Celesio H1 revenue decreases
Nov 22,2016: Celesio reports first half of fiscal 2017 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • CVS Health Corporation
  • Europa Apotheek Venlo BV
  • Mediq NV
  • MORE
Section 1 - About the Company
Celesio AG - Key Facts
Celesio AG - Key Employees
Celesio AG - Major Products and Services
Celesio AG - History
Celesio AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

Section 2 - Company Analysis
Celesio AG - Business Description
Business Description - Consumer Solutions
Consumer Solutions - Overview
Consumer Solutions - Financials
Business Description - Pharmacy Solutions
Pharmacy Solutions - Overview
Pharmacy Solutions - Financials
Celesio AG - Corporate Strategy
Celesio AG - SWOT Analysis
SWOT Analysis - Overview
Celesio AG - Strengths
Celesio AG - Weaknesses
Celesio AG - Opportunities
Celesio AG - Threats
Celesio AG - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Celesio AG, Recent Deals Summary

Section 4 - Company’s Recent Developments
Jun 23, 2017: Celesio revenue grows by 5.8 percent on constant currency basis and excluding disposals
Feb 03, 2017: Celesio UK appoints new digital director
Jan 16, 2017: Celesio announces management changes
Nov 22, 2016: Celesio H1 revenue decreases
Nov 22, 2016: Celesio reports first half of fiscal 2017 results

Section 5 - Appendix
Methodology
Ratio Definitions

About the Publisher
Contact Us
Disclaimer

List of Tables
Celesio AG, Key Facts
Celesio AG, Key Employees
Celesio AG, Major Products and Services
Celesio AG, History
Celesio AG, Subsidiaries
Celesio AG, Joint Venture
Celesio AG, Key Competitors
Celesio AG, Ratios based on current share price
Celesio AG, Annual Ratios
Celesio AG, Annual Ratios (Cont
Celesio AG, Annual Ratios (Cont
Celesio AG, Interim Ratios
Celesio AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Celesio AG, Performance Chart (2013 - 2017)
Celesio AG, Ratio Charts
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Walgreens Boots Alliance, Inc.
  • Phoenix Pharmahandel GmbH & Co KG
  • Mediq NV
  • Europa Apotheek Venlo BV
  • CVS Health Corporation
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll